ω-3 fatty acids in the prevention of cognitive decline in humans.
about
Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's diseaseDocosahexaenoic Acid and Cognition throughout the LifespanNutrients, Microglia Aging, and Brain AgingDiet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional InterventionsImpact of Genotype on EPA and DHA Status and Responsiveness to Increased IntakesPPARα signaling in the hippocampus: crosstalk between fat and memoryEffects of diet on brain plasticity in animal and human studies: mind the gap.Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's diseaseOmega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methodsThe beneficial role of anti-inflammatory dietary ingredients in attenuating markers of chronic low-grade inflammation in aging.Hot Topics in Research: Preventive Neuroradiology in Brain Aging and Cognitive Decline.Changes in Oxidative Stress and Inflammatory Biomarkers in Fragile Adults over Fifty Years of Age and in Elderly People Exclusively Fed Enteral NutritionLipidomics and H2(18)O labeling techniques reveal increased remodeling of DHA-containing membrane phospholipids associated with abnormal locomotor responses in α-tocopherol deficient zebrafish (danio rerio) embryosBipolar Depression and Cognitive Impairment: Shared Mechanisms and New Treatment Avenues.The relationship between omega-3 and smoking habit: a cross-sectional study.Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation.The n-3 Polyunsaturated Fatty Acids Supplementation Improved the Cognitive Function in the Chinese Elderly with Mild Cognitive Impairment: A Double-Blind Randomized Controlled Trial.Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration.Therapeutic Strategies for Leukodystrophic Disorders Resulting from Perinatal Asphyxia: Focus on Myelinating Oligodendrocytes.Plasma n-3 polyunsaturated fatty status and its relationship with vitamin E intake and plasma level.Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice.Low-level mercury, omega-3 index and neurobehavioral outcomes in an adult US coastal population.Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and Repair.Impact of dietary fats on brain functions.Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting.Protection Before Impact: the Potential Neuroprotective Role of Nutritional Supplementation in Sports-Related Head Trauma.n-3 Polyunsaturated fatty acid supplementation restored impaired memory and GABAergic synaptic efficacy in the hippocampus of stressed rats.Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery Occlusion and Reperfusion.Z-Guggulsterone Improves the Scopolamine-Induced Memory Impairments Through Enhancement of the BDNF Signal in C57BL/6J Mice.Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide.Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?Subjective memory complaints in elderly: relationship with health status, multimorbidity, medications, and use of services in a population-based study.Prospective Associations of Erythrocyte Composition and Dietary Intake of -3 and -6 PUFA with Measures of Cognitive Function
P2860
Q26766462-149C97D6-E748-4846-9706-1817F184A1D6Q26768442-00B9988E-6F16-458A-99C0-4A20F203258FQ26768461-F0403575-C607-48D9-9658-7900B3DD97FFQ26798129-CF0FB0E3-8BF7-4786-B147-B976B1CAADACQ28077212-C72FC550-4F59-4A54-B4BC-868E8FF567E2Q28082348-945D5DA0-EDE4-4202-B3E4-3FEBBC6A75AAQ33679165-DDD82A54-687F-4866-82B2-897C3B6C3AF5Q33793583-A4254346-F500-43EA-8728-2E4DA392AEEBQ34669624-19E946D9-A82C-4130-B977-3A3E765C6CEFQ35678169-FE7934AC-D9DA-45D2-99E2-E60D027A2AD1Q36144678-95C7810F-6A21-44AE-B435-867EEF7BF9D2Q36369055-071B44EF-DD14-4CF4-B059-FDC236BA5817Q36517718-4653D46B-28D0-4BBE-A434-AE60B21B92A3Q36592329-11C30E0A-7899-4317-98BC-6F8DB561DA4AQ36720400-65C5D604-139A-4A42-847C-1E10C0888B9EQ37510384-6F72D10E-4CA5-4961-A1E3-71DD34A15169Q37628428-DF52A622-96C1-4A63-86B4-DD89775759DFQ38403214-35BB91A6-749A-4A0F-9E06-F46770270D14Q38515285-336301AD-CD6D-4E48-A215-7B329F5D8797Q39404025-08BBE480-9292-4DE1-B5E7-50E80BB8710EQ39961769-518A87E2-EB99-484C-A1FB-66EC749503D3Q41217789-61587835-BC0A-43C4-AE98-63F07D386543Q41363364-E966F179-D994-4622-AB5D-DD28DD626CC9Q47120837-9D66515E-3C09-46D5-A31A-6959ED0CC7A9Q47290017-218DF7A9-EE98-457F-85D0-41C4C8140EC6Q47408666-C504F5C8-A3CC-40E0-AD40-77B44A95486EQ47840928-4DC7512E-52E9-44A9-8929-7F483A0AB6C8Q47893464-0A2C19C9-08B7-4823-9394-6D7649CA269DQ48133937-C24063E7-47B1-4CA5-84DF-AF1FC6AA04FAQ48494260-7A41DCAA-F2F3-4650-A2F1-6C80F9F74101Q48748992-6FB3193D-979F-47CD-93F0-64E0D7A43A4DQ49885017-1446A1D2-F59B-4BFC-9CA5-AC58C7C82664Q50348954-4E9914C3-7CCE-48CD-9E35-8076472BD79DQ58575068-F9F03A74-869D-4120-9319-7A590A2BE314
P2860
ω-3 fatty acids in the prevention of cognitive decline in humans.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
ω-3 fatty acids in the prevention of cognitive decline in humans.
@ast
ω-3 fatty acids in the prevention of cognitive decline in humans.
@en
ω-3 fatty acids in the prevention of cognitive decline in humans.
@nl
type
label
ω-3 fatty acids in the prevention of cognitive decline in humans.
@ast
ω-3 fatty acids in the prevention of cognitive decline in humans.
@en
ω-3 fatty acids in the prevention of cognitive decline in humans.
@nl
prefLabel
ω-3 fatty acids in the prevention of cognitive decline in humans.
@ast
ω-3 fatty acids in the prevention of cognitive decline in humans.
@en
ω-3 fatty acids in the prevention of cognitive decline in humans.
@nl
P2860
P356
P1476
ω-3 fatty acids in the prevention of cognitive decline in humans.
@en
P2093
Norman Salem
Tommy Cederholm
P2860
P304
P356
10.3945/AN.113.004556
P407
P50
P577
2013-11-06T00:00:00Z